These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 22541290)

  • 1. Neurological phenotypes for Down syndrome across the life span.
    Lott IT
    Prog Brain Res; 2012; 197():101-21. PubMed ID: 22541290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gait dyspraxia as a clinical marker of cognitive decline in Down syndrome: A review of theory and proposed mechanisms.
    Anderson-Mooney AJ; Schmitt FA; Head E; Lott IT; Heilman KM
    Brain Cogn; 2016 Apr; 104():48-57. PubMed ID: 26930369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer's disease phenotypes.
    García-Cerro S; Rueda N; Vidal V; Lantigua S; Martínez-Cué C
    Neurobiol Dis; 2017 Oct; 106():76-88. PubMed ID: 28647555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unraveling the complexity of neurodegeneration in brains of subjects with Down syndrome: insights from proteomics.
    Perluigi M; Di Domenico F; Buttterfield DA
    Proteomics Clin Appl; 2014 Feb; 8(1-2):73-85. PubMed ID: 24259517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down syndrome individuals with Alzheimer's disease have a distinct neuroinflammatory phenotype compared to sporadic Alzheimer's disease.
    Wilcock DM; Hurban J; Helman AM; Sudduth TL; McCarty KL; Beckett TL; Ferrell JC; Murphy MP; Abner EL; Schmitt FA; Head E
    Neurobiol Aging; 2015 Sep; 36(9):2468-74. PubMed ID: 26103884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain-predicted age in Down syndrome is associated with beta amyloid deposition and cognitive decline.
    Cole JH; Annus T; Wilson LR; Remtulla R; Hong YT; Fryer TD; Acosta-Cabronero J; Cardenas-Blanco A; Smith R; Menon DK; Zaman SH; Nestor PJ; Holland AJ
    Neurobiol Aging; 2017 Aug; 56():41-49. PubMed ID: 28482213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical aging in Down syndrome.
    Zigman WB
    Dev Disabil Res Rev; 2013; 18(1):51-67. PubMed ID: 23949829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrovascular contributions to aging and Alzheimer's disease in Down syndrome.
    Wilcock DM; Schmitt FA; Head E
    Biochim Biophys Acta; 2016 May; 1862(5):909-14. PubMed ID: 26593849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signalling Pathways Implicated in Alzheimer's Disease Neurodegeneration in Individuals with and without Down Syndrome.
    Martínez-Cué C; Rueda N
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32962300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-amyloid, oxidative stress and down syndrome.
    Lott IT; Head E; Doran E; Busciglio J
    Curr Alzheimer Res; 2006 Dec; 3(5):521-8. PubMed ID: 17168651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible compensatory events in adult Down syndrome brain prior to the development of Alzheimer disease neuropathology: targets for nonpharmacological intervention.
    Head E; Lott IT; Patterson D; Doran E; Haier RJ
    J Alzheimers Dis; 2007 Mar; 11(1):61-76. PubMed ID: 17361036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PET Imaging of Tau Pathology and Relationship to Amyloid, Longitudinal MRI, and Cognitive Change in Down Syndrome: Results from the Down Syndrome Biomarker Initiative (DSBI).
    Rafii MS; Lukic AS; Andrews RD; Brewer J; Rissman RA; Strother SC; Wernick MN; Pennington C; Mobley WC; Ness S; Matthews DC;
    J Alzheimers Dis; 2017; 60(2):439-450. PubMed ID: 28946567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-IL17 treatment ameliorates Down syndrome phenotypes in mice.
    Rueda N; Vidal V; García-Cerro S; Narcís JO; Llorens-Martín M; Corrales A; Lantigua S; Iglesias M; Merino J; Merino R; Martínez-Cué C
    Brain Behav Immun; 2018 Oct; 73():235-251. PubMed ID: 29758264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain insulin resistance triggers early onset Alzheimer disease in Down syndrome.
    Tramutola A; Lanzillotta C; Di Domenico F; Head E; Butterfield DA; Perluigi M; Barone E
    Neurobiol Dis; 2020 Apr; 137():104772. PubMed ID: 31987911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between frontal cortex oxidative damage and beta-amyloid as a function of age in Down syndrome.
    Cenini G; Dowling AL; Beckett TL; Barone E; Mancuso C; Murphy MP; Levine H; Lott IT; Schmitt FA; Butterfield DA; Head E
    Biochim Biophys Acta; 2012 Feb; 1822(2):130-8. PubMed ID: 22009041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shaping down syndrome brain cognitive and molecular changes due to aging using adult animals from the Ts66Yah murine model.
    Lanzillotta C; Baniowska MR; Prestia F; Sette C; Nalesso V; Perluigi M; Barone E; Duchon A; Tramutola A; Herault Y; Di Domenico F
    Neurobiol Dis; 2024 Jun; 196():106523. PubMed ID: 38705491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HNE-modified proteins in Down syndrome: Involvement in development of Alzheimer disease neuropathology.
    Barone E; Head E; Butterfield DA; Perluigi M
    Free Radic Biol Med; 2017 Oct; 111():262-269. PubMed ID: 27838436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Communication breaks-Down: from neurodevelopment defects to cognitive disabilities in Down syndrome.
    Contestabile A; Benfenati F; Gasparini L
    Prog Neurobiol; 2010 May; 91(1):1-22. PubMed ID: 20097253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropathological correlates of amyloid PET imaging in Down syndrome.
    Abrahamson EE; Head E; Lott IT; Handen BL; Mufson EJ; Christian BT; Klunk WE; Ikonomovic MD
    Dev Neurobiol; 2019 Jul; 79(7):750-766. PubMed ID: 31379087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective neuroanatomic abnormalities in Down's syndrome and their cognitive correlates: evidence from MRI morphometry.
    Raz N; Torres IJ; Briggs SD; Spencer WD; Thornton AE; Loken WJ; Gunning FM; McQuain JD; Driesen NR; Acker JD
    Neurology; 1995 Feb; 45(2):356-66. PubMed ID: 7854539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.